Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where procedure options remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/top-analyst-says-to-buy-xrp-and-solaxy-for-the-biggest-gains-in-2025/